Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2005

View Archived Issues

New data on the pharmacokinetics of 667-Coumate in rats

Enrollment completed in phase II PAOD trial of NCX-4016

Sention to develop mGluR antagonists for Fragile X mental retardation

Jerini and Alcon collaborate on novel ophthalmology drugs

Novartis grants Meda European rights to Cibacen and Cibadrex

Novartis: pipeline review

Novel TRPV1 antagonist effective in animal model of inflammatory pain

Efficacy of R-135853 in mouse candidiasis

Researchers at Leiden University synthesize a novel ENT1 inhibitor

Rigel and Pfizer sign collaborative and license agreement for respiratory diseases

GenVec signs malaria vaccine contract with Department of Defense

Phase I study investigates pralatrexate in NSCLC

Copernicus receives award to advance genetic therapy for cystic fibrosis

Pegasys receives positive opinion in E.U. for hepatitis B

Antiinflammatory compounds described in a patent

Scientists at Pfizer claim beta2-adrenoceptor agonists for respiratory diseases

Novel gamma-secretase inhibitors for the treatment of Alzheimer's disease reported by Roche

Agents for the treatment of estrogen-dependent diseases described in a patent

New anticoagulant agents from Bayer

Several GSK and Pliva patents cover antibacterial agents

Depression reported to reduce the efficacy of IFN-alpha plus ribavirin in hepatitis C

Zolmitriptan nasal spray provides effective total pain relief in migraine patients

Improved gastrointestinal recovery found with MNTX after abdominal surgery

Update on the efficacy and safety of viramidine in chronic hepatitis C

Good safety profile found for PYM-50028 in AD patients

VRPs expressing HER2/neu prevent breast cancer growth and tumorigenesis in mice

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...